Skip to main content

Developing Novel Immunotherapies for Challenging Lymphomas

dr. Fehniger

Todd Fehniger


Washington University in St. Louis

Project Term: October 1, 2023 - September 30, 2028

This team science program from Washington University will develop new immunotherapy treatments for patients with hard to treat or incurable lymphomas. The team includes physicians and scientists who have developed new ideas in the laboratory for immune-based treatment, and will translate these to clinical trial testing. These include engineered natural kill cells, healthy donors T cell engineered to attack a T cell lymphoma, and lymphoma-patient specific mutations as vaccine targets.

Lay Abstract

Coming soon.

Specialized Center of Research Program
To All Projects